Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
about
A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.Evidence at a glance: error matrix approach for overviewing available evidenceData monitoring committees, interim analysis and early termination in paediatric trials.A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosisDesigning Oversight for Nanomedicine Research in Human Subjects: Systematic Analysis of Exceptional Oversight for Emerging Technologies.Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary reportStopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)Bayesian statistics in oncology: a guide for the clinical investigator.Reflections on meta-analyses involving trials stopped early for benefit: is there a problem and if so, what is it?Stopping trials early for benefit--not so fast!A non-paternalistic model of research ethics and oversight: assessing the benefits of prospective review.Study design and "evidence" in patient-oriented research.The JUPITER trial: myth or reality?Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.Bayes factor design analysis: Planning for compelling evidence.Publishing interim results of randomised clinical trials in peer-reviewed journals.Stopping clinical trials early for benefit: impact on estimation.Monitoring in clinical trials: benefit or bias?Stopping trials for efficacy: an almost unbiased view.How should adverse events be reported in US clinical trials?: ethical considerations.External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial.Bias, Operational Bias, and Generalizability in Phase II/III Trials.
P2860
Q33517961-DC133784-AF7E-420B-99A1-C1D6E10BD635Q33710053-D1562C58-7904-474B-8A3E-2135FBACF6D2Q33854726-0EEB7D36-EA63-499B-9253-F72F50923858Q35042658-9E7F45F1-A235-447F-8C69-24B64C53676DQ36447479-28F41557-209D-4E3C-A223-6111550CF50FQ37037489-8A5244D4-63E5-4DF5-8536-69734A632BDFQ37158281-1047FBE0-FA98-4F01-BC0B-5D56FAB1C265Q37295343-FF339DCC-B33C-4D9C-9DA9-307CE2B2A5ADQ37582338-07145079-47BD-48BD-A24B-856B37E1AED1Q37968574-D054CBAB-70B7-4C60-953F-2C9253D53BBAQ38058499-71833DD5-0504-4717-904E-F8B0A81D5710Q38071677-B51CF650-094C-4A10-B5FF-77ADA62C0A02Q38110966-A34FAEF8-06C3-49A2-9534-E83050C7AF6DQ38462688-651E30C0-4BB3-4554-8F88-B0DAF6D4CCEAQ38707747-6112A81B-BB78-4E7C-93AA-DA5F5C0ED9DBQ38856986-AF6216CD-6F98-4942-9711-DF74439ED308Q38934243-8BF554E5-4CB3-4FEE-AC4B-2EB2A8042CB6Q39021028-7914A381-EC56-453F-9D02-A9323D77AC42Q43612678-AC882E3A-36FC-4F97-A5E2-3E6E012F64A5Q44902803-15B6B5F7-E5D1-48B0-8D65-FE5A4F5C77DCQ45073427-BA414FD0-9B9E-41DE-B336-E2431212BB58Q47884239-B83A82D9-A361-4F9C-920C-87E8B9AF9FEAQ52312736-8BA2102C-273F-40B8-B9C8-75558CB88B26Q53281780-234A61EC-E6FC-4BB9-804D-3CC05EDA8F93
P2860
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@ast
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@en
type
label
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@ast
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@en
prefLabel
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@ast
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@en
P1476
Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
@en
P2093
Steven N Goodman
P304
P356
10.7326/0003-4819-146-12-200706190-00010
P407
P577
2007-06-01T00:00:00Z